Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. Methods Ferroptosis-related genes (FRGs) were id...
Salvato in:
Autori principali: | , , , , , |
---|---|
Natura: | Artigo |
Lingua: | inglese |
Pubblicazione: |
2020
|
Accesso online: | https://doi.org/10.3389/fcell.2020.596679 https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/pdf |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|